Cardiac Arrhythmia, Sudden Death, and Psychoactive Agents
1987; Wiley; Volume: 27; Issue: 1 Linguagem: Inglês
10.1177/009127008702700101
ISSN1552-4604
AutoresClaire M. Lathers, Leslie Lipka,
Tópico(s)Treatment of Major Depression
ResumoThe Journal of Clinical PharmacologyVolume 27, Issue 1 p. 1-14 Cardiac Arrhythmia, Sudden Death, and Psychoactive Agents Claire M. Lathers PhD, FCP, Corresponding Author Claire M. Lathers PhD, FCP Department of Pharmacology, The Medical College of Pennsylvania, Philadelphia, Pennsylvania.Department of Pharmacology, The Medical College of Pennsylvania, 3300 Henry Avenue, Philadelphia, PA 19129.Search for more papers by this authorLeslie J. Lipka, Leslie J. Lipka L. J. Lipka to complete the requirements for the MD, PhD, degrees. L.J. Lipka was a recipient of a 1983–1985 Advanced Predoctoral Fellowship from the Pharmaceutical Manufacturers Association Foundation, Inc.Search for more papers by this author Claire M. Lathers PhD, FCP, Corresponding Author Claire M. Lathers PhD, FCP Department of Pharmacology, The Medical College of Pennsylvania, Philadelphia, Pennsylvania.Department of Pharmacology, The Medical College of Pennsylvania, 3300 Henry Avenue, Philadelphia, PA 19129.Search for more papers by this authorLeslie J. Lipka, Leslie J. Lipka L. J. Lipka to complete the requirements for the MD, PhD, degrees. L.J. Lipka was a recipient of a 1983–1985 Advanced Predoctoral Fellowship from the Pharmaceutical Manufacturers Association Foundation, Inc.Search for more papers by this author First published: January 1987 https://doi.org/10.1177/009127008702700101Citations: 32 AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat References 1 Domino EF: Sudden death, acute and chronic extrapyramidal syndromes including tardive dyskinesia and self-mutilation induced by fluphenazine and haloperidol in monkeys. Society for Neuroscience Abstracts 1983; 9. Google Scholar 2 Domino EF, Kovacic B: Monkey models of tardive dyskinesia, in E Usdin, A Carlsson, A Dahlstrom, J Engel (eds): Catecholamines: Neuropharmacology and Central Nervous System—The Therapeutic Aspect. New York, Alan R. Liss, 1984. Google Scholar 3 Domino EF: Sudden death and neuroleptic medication in subhuman primates. Am J Psychiatry 1985; 142: 145. 10.1176/ajp.142.1.145a CASPubMedWeb of Science®Google Scholar 4 Kelly HG, Fay JE, Laverty SG: Thioridazine hydrochloride (Mellaril): Its effect on the electrocardiogram and a report of two fatalities with electrocardiographic abnormalities. Can Med Assoc J 1963; 89: 546–554. CASPubMedWeb of Science®Google Scholar 5 Hollister LE, Kosek JC: Sudden death during treatment with phenothiazine derivatives. JAMA 1965; 192; 93–96. 10.1001/jama.1965.03080250013003 Google Scholar 6 Leestma JE, Koenig KL: Sudden death and phenothiazines: A current controversy. Arch Gen Psychiatry 1968; 18: 137–148. 10.1001/archpsyc.1968.01740020009002 Web of Science®Google Scholar 7 Jefferson, JW: A review of the cardiovascular effects and toxicity of tricyclic antidepressants. N Engl J Med 1975; 299: 1168–1172. PubMedWeb of Science®Google Scholar 8 Fowler NO, McCall D, Te-Chuan C, et al: Electrocardiographic changes and cardiac arrhythmias in patients receiving psychotropic drugs. Am J Cardiol 1976; 37: 223–230. 10.1016/0002-9149(76)90316-7 CASPubMedWeb of Science®Google Scholar 9 Burgess KR, Jefferis RW, Stevenson IF: Fatal thioridazine cardiotoxicity. Med J Aust 1979; 2: 177–178. 10.5694/j.1326-5377.1979.tb142025.x CASPubMedWeb of Science®Google Scholar 10 Lipscomb PA: Cardiovascular side effects of phenothiazines and tricyclic antidepressants: A review with precautionary measures. Postgrad Med 1980; 67: 189–196. 10.1080/00325481.1980.11715402 CASPubMedWeb of Science®Google Scholar 11 Reid W, Harrower ADB: Cardiac arrest after apparent recovery from an overdose of chlorpromazine. Br Med J 1984; 228: 1880. Google Scholar 12 Coull DS, Crooks J, Dingwall-Fordyce K, et al: A method of monitoring drugs for adverse reaction. II: Amitriptyline and cardiac disease. Eur J Clin Pharmacol 1970; 3: 51–55. 10.1007/BF00560292 Web of Science®Google Scholar 13 Coull DS, Crooks J, Dingwall-Fordyce K, et al: Amitriptyline and cardiac disease. Lancet 1970; 2: 590–591. 10.1016/S0140-6736(70)90169-8 CASPubMedWeb of Science®Google Scholar 14 Williams RB Jr, Sherter C: Cardiac complications of tricyclic antidepressant therapy. Ann Intern Med 1971; 74: 395–398. 10.7326/0003-4819-74-3-395 PubMedWeb of Science®Google Scholar 15 Byck R: Drugs and the treatment of psychiatric disorders, in LS Goodman, A Gilman (eds): The Pharmacological Basis of Therapeutics. 5th Ed. New York, Macmillan, 1975; 152–200. Google Scholar 16 Langou RA, Van Dyke C, Tahan SR, et al: Cardiovascular manifestations of tricyclic antidepressant overdose. Am Heart J 1980; 27: 183–192. Google Scholar 17 Amitryptilene and cardiac disease (editorial). Med J Aust 1970; 2: 940–941. 10.5694/j.1326-5377.1970.tb63280.x PubMedWeb of Science®Google Scholar 18 Moir DC, Crooks J, Sawyer P, et al: Cardiotoxicity of tricyclic antidepressants. Br J Pharmacol 1972; 44: 371P–372P. CASPubMedWeb of Science®Google Scholar 19 Crawley IS, Kolodner RM: The effects of psychotropic drugs on the heart, in JW Hurst (ed): Clinical Essays on the Heart. New York, McGraw-Hill, 1981; 285–311. Google Scholar 20 Alexander CS, Nino A: Cardiovascular complications in young patients taking psychotropic drugs. Am Heart J 1969; 78: 757–769. 10.1016/0002-8703(69)90442-6 CASPubMedWeb of Science®Google Scholar 21 Nasrallah HA: Factors influencing phenothiazine-induced ECG changes. Am J Psychiatry 1978; 135: 118–119. 10.1176/ajp.135.1.118 CASPubMedWeb of Science®Google Scholar 22 Axelsson R, Aspenstrom G: Electrocardiographic changes and serum concentrations in thioridazine-treated patients. J Clin Psychiatry 1982; 43: 332–335. PubMedWeb of Science®Google Scholar 23 Tri TB, Combs DT: Phenothiazine induced ventricular tachycardia. West J Med 1975; 123: 412–416. CASPubMedWeb of Science®Google Scholar 24 Huston JR, Bell GE: The effect of thioridazine hydrochloride and chlorpromazine on the electrocardiogram. JAMA 1966; 198: 134–138. 10.1001/jama.198.1.134 CASPubMedGoogle Scholar 25 Surawicz B, Knoebel SB: Long QT: Good, bad or indifferent? J Am Coll Cardiol 1984; 4: 398–411. 10.1016/S0735-1097(84)80232-6 CASPubMedWeb of Science®Google Scholar 26 Surawicz B, Lasseter KC: Effect of drugs on the electrocardiogram. Prog Cardiovasc Dis 1970; 13: 26–54. Google Scholar 27 Langslet A: Changes in coronary flow and ECG in the isolated perfused rat heart induced by phenothiazine drugs. Acta Pharmacol Toxicol 1969; 27: 183–192. 10.1111/j.1600-0773.1969.tb00505.x CASPubMedWeb of Science®Google Scholar 28 Langslet A: ECG-changes induced by phenothiazine drugs in the anesthetized rat. Acta Pharmacol Toxicol 1970; 28: 258–264. 10.1111/j.1600-0773.1970.tb00552.x CASPubMedWeb of Science®Google Scholar 29 Aronson CE, Serlick ER: Effects of chlorpromazine on the isolated perfused rat heart. Toxicol Appl Pharmacol 1977; 39: 157–176. 10.1016/0041-008X(77)90150-8 CASPubMedWeb of Science®Google Scholar 30 Bianchetti G, Bonaccorsi A, Chiodaroli A, et al: Plasma concentrations and cardiotoxic effects of desipramine and protriptyline in the rat. Br J Pharmacol 1977; 60: 11–19. 10.1111/j.1476-5381.1977.tb16741.x CASPubMedWeb of Science®Google Scholar 31 Burckhardt D, Raeder E, Muller V, et al: Cardiovascular effects of tricyclic and tetracyclic antidepressants. JAMA 1978; 239: 213–216. 10.1001/jama.1978.03280300045019 CASPubMedWeb of Science®Google Scholar 32 Boehnert MT, Lovejoy FJ: Value of the QRS duration versus the serum drug level in predicting seizures and ventricular arrhythmias after an acute overdose of tricyclic antidepressants. N Engl J Med 1985; 313: 474–479. 10.1056/NEJM198508223130804 CASPubMedWeb of Science®Google Scholar 33 Bigger JT, Giardina EGV, Perel JM, et al: Cardiac antiarrhythmic effect of imipramine hydrochloride. N Engl J Med 1977; 296: 206–208. 10.1056/NEJM197701272960407 CASPubMedWeb of Science®Google Scholar 34 Rudorfer MV, Young RC: Desipramine: Cardiovascular effects and plasma levels. Am J Psychiatry 1980; 137: 984–986. 10.1176/ajp.137.8.984 CASPubMedWeb of Science®Google Scholar 35 Jakobsen J, Hauksson P, Veslergaard P: Heart rate variation in patients treated with antidepressants. An index of anticholinergic effects? Psychopharmacology 1984; 84: 544–548. 10.1007/BF00431464 CASPubMedWeb of Science®Google Scholar 36 Bennet T: Physiologic investigation of diabetic autonomic failure, in R Bannister (ed): Autonomic Failure. A Textbook of Clinical Disorders of the Autonomic Nervous System. Oxford, Oxford University Press, 1983; 406–436. Google Scholar 37 Angelone A, Coulter NA: Respirator sinus arrhythmia. A frequency dependent phenomenon. J Appl Physiol 1964; 19: 479–482. 10.1152/jappl.1964.19.3.479 CASPubMedWeb of Science®Google Scholar 38 Pfeifer MA, Cook D, Brodsky J, et al: Quantitative evaluation of cardiac parasympathetic activity in normal and diabetic man. Diabetes 1982; 31: 339–345. 10.2337/diab.31.4.339 CASPubMedWeb of Science®Google Scholar 39 Roberts J, Kelliher GJ: Adrenergic innervation of the heart as a site for the genesis and control of arrhythmia. Recent advances in studies on cardiac structure and metabolism, in NS Dhalla (ed): Myocardial Metabolism. Baltimore, University Park Press, 1973; 357–366. Google Scholar 40 Levitt B, Cagin NA, Somberg JC, et al: Neural basis for the genesis and control of digitalis arrhythmias. Cardiology 1976; 61: 50–60. 10.1159/000169747 CASPubMedWeb of Science®Google Scholar 41 Lathers CM, Roberts J, Kelliher GJ: Correlation of ouabain-induced arrhythmia and nonuniformity in the histamine-evoked discharge of cardiac sympathetic nerves. J Pharmacol Exp Ther 1977; 203: 467–479. CASPubMedWeb of Science®Google Scholar 42 Lathers CM, Kelliher GJ, Roberts J, et al: Nonuniform cardiac sympathetic nerve discharge: Mechanism for coronary occlusion and digitalis-induced arrhythmia. Circulation 1978; 57: 1058–1065. 10.1161/01.CIR.57.6.1058 CASPubMedWeb of Science®Google Scholar 43 PJ Schwartz, AM Brown, A Malliani, A Zanchettia, (eds) : Neural Mechanisms in Cardiac Arrhythmias. vol 2. Raven Press, New York, 1978. Google Scholar 44 Malliani A, Schwartz PJ, Zanchetti A: Neural mechanisms in life-threatening arrhythmias. Am Heart J 1980; 100: 705–715. 10.1016/0002-8703(80)90238-0 PubMedWeb of Science®Google Scholar 45 Roberts J, Kelliher GJ, Lathers CM: Minireview: Role of adrenergic influences in digitalis-induced ventricular arrhythmia. Life Sci 1976; 18: 665–678. 10.1016/0024-3205(76)90177-6 CASPubMedWeb of Science®Google Scholar 46 Gillis RA, Quest JA, Diaz Diaz J: The role of the nervous system in the cardiovascular effects of digitalis. Pharmacol Rev 1979; 31: 19–97. CASPubMedWeb of Science®Google Scholar 47 Lathers CM, Roberts J: Minireview: Digitalis cardiotoxicity revisited. Life Sci 1980; 27: 1713–1733. 10.1016/0024-3205(80)90439-7 CASPubMedWeb of Science®Google Scholar 48 Lathers CM, Lipka LJ, Klions HA: Controversies in the actions of digitalis substances: Are all digitalis derivatives alike?: J Clin Pharmacol 1985; 25: 501–506. 10.1177/009127008502500705 CASPubMedWeb of Science®Google Scholar 49 Sherif MAF, Chata MK, Madkour MK: Action of chlorpromazine on autonomic ganglia. Arch Int Pharmacodyn Ther 1958; 115; 269–277. CASPubMedWeb of Science®Google Scholar 50 Carpenter P, Gobel FL, Hulsing DJ: Desipramine cardiac toxicity. Minn Med 1982; 65: 231–234. CASPubMedWeb of Science®Google Scholar 51 Schallek W, Zabransky F: Effects of psychotropic drugs on pressor responses to central and peripheral stimulation in cat. Arch Int Pharmacodyn Ther 1966; 161: 126–131. CASPubMedWeb of Science®Google Scholar 52 Chai CY, Wang SC: Cardiovascular actions of diazepam in the cat. J Pharmacol Exp Ther 1966; 154: 271–280. CASPubMedWeb of Science®Google Scholar 53 Sigg EB, Sigg TD: Hypothalamic stimulation of preganglionic autonomic activity and its modification by chlorpromazine, diazepam and pentobarbital. Int J Neuropharmacol 1969; 8: 567–572. 10.1016/0028-3908(69)90073-2 CASPubMedWeb of Science®Google Scholar 54 Sigg EB, Keim KL, Kepner K: Selective effect of diazepam on certain central sympathetic components. Neuropharmacology 1971; 10: 621–629. 10.1016/0028-3908(71)90028-1 CASPubMedWeb of Science®Google Scholar 55 Hockman CH, Livingston KE: Inhibition of reflex vagal bradycardia by diazepam. Neuropharmacology 1971; 10: 307–314. 10.1016/0028-3908(71)90054-2 CASPubMedWeb of Science®Google Scholar 56 Raisfeld IH: Cardiovascular complications of antidepressant therapy. Interactions at the adrenergic neuron. Am Heart J 1972; 83: 129–133. 10.1016/0002-8703(72)90114-7 CASPubMedWeb of Science®Google Scholar 57 Kiem KL, Sigg EB: Vagally mediated cardiac reflexes and their modulation by diazepam and pentobarbital. Neuropharmacology 1973; 12: 319–325. 10.1016/0028-3908(73)90091-9 PubMedWeb of Science®Google Scholar 58 Guzman-Harty M, Tjioe SA, O'Neill JJ: Effects of chlorpromazine and its dihydroxy metabolite on calcium movement and electrical activity in superior cervical ganglia. Arch Toxicol 1985; 56: 272–278. 10.1007/BF00295167 CASPubMedWeb of Science®Google Scholar 59 Baum T, Shropshire AT, Rowles G, et al: Antidepressants and cardiac conduction: Iprindole and imipramine. Eur J Pharmacol 1971; 13: 287–291. 10.1016/0014-2999(71)90216-0 CASPubMedWeb of Science®Google Scholar 60 Cairncross KD, Gershon S: A pharmacological basis for the cardiovascular complications of imipramine intoxication Med J Aust 1962; 2: 373–375. Google Scholar 61 Fiedler VB, Gobel H, Nitz RE: Cardioprotective effects of carbocromen in awake and anesthetized dogs with amitriptyline poisoning. J Cardiovasc Pharmacol 1985; 7: 666–672. 10.1097/00005344-198507000-00009 CASPubMedWeb of Science®Google Scholar 62 Fiedler VB, Kettenback B, Gobel H, et al: Treatment of haemodynamic and electrocardiographic side-effects resulting from imipramine toxicity in rats and dogs. Naunyn-Schmiedeberg's Arch Pharmacol 1985; 330: 155–161. 10.1007/BF00499909 CASPubMedWeb of Science®Google Scholar 63 Nattel S, Mitterman M: Treatment of ventricular tachyarrhythmias resulting from amitriptyline toxicity in dogs. J Pharmacol Exp Ther 1984; 231: 430–435. CASPubMedWeb of Science®Google Scholar 64 Spiss CK, Smith CM, Maze M: Halothane-epinephrine arrhythmias and adrenergic responsiveness after chronic imipramine administration in dogs. Anesth Analog 1984; 63: 825–828. 10.1213/00000539-198409000-00007 CASPubMedWeb of Science®Google Scholar 65 Giardina EGV, Bigger JT, Glassman AH, et al: The electrocardiographic and antiarrhythmic effects of imipramine hydrochloride at therapeutic plasma concentrations. Circulation 1979; 60: 1045–1052. 10.1161/01.CIR.60.5.1045 CASPubMedWeb of Science®Google Scholar 66 Connoly SJ, Mitchell LB, Swerdlou CD, et al: Clinical efficacy and electrophysiology of imipramine for ventricular tachycardia. Am J Cardiol 1984; 53: 516–521. 10.1016/0002-9149(84)90023-7 PubMedWeb of Science®Google Scholar 67 Manoach M, Kauli N, Netz H, et al: Dibenzepin as an antifibrillatory agent for spontaneous terminating electrically induced ventricular fibrillation. Isr J Med Sci 1979; 15: 443–447. CASPubMedWeb of Science®Google Scholar 68 Netz H, Manoach, M, Aygen M, et al: Effect of dibenzepin on ventricular fibrillation in cat and dog following coronary occlusion, in F De-Padua, PW MacFarlane (eds): New Frontiers in Electrocardiology. London, Research Studies Press, Wiley and Sons, 1981; 102–107. Google Scholar 69 Manoach M, Watanbe Y, Hiroki T: Cardiac protective effects of tricyclic antidepressants. Am J Cardiol 1984; 54: 941. 10.1016/S0002-9149(84)80268-4 CASPubMedWeb of Science®Google Scholar 70 Yoon MS, Han J, Dersham GH, et al: Effects of thioridazine (Mellaril) on ventricular electrophysiologic properties. Am J Cardiol 1979; 43: 1155–1158. 10.1016/0002-9149(79)90147-4 CASPubMedWeb of Science®Google Scholar 71 Davis JC, Bigger JT Jr: The effects of thioridazine on electrical and ischemic ventricular fibrillation in the dog heart in situ. J Pharmacol Exp Ther 1981; 216: 39–44. CASPubMedWeb of Science®Google Scholar 72 Yagielo J, Duffin SR, Hunt LM: Drug interactions and vasoconstrictors used in local anesthetic solutions. Oral Surg Oral Med Oral Path 1985; 59: 565–571. 10.1016/0030-4220(85)90181-1 PubMedWeb of Science®Google Scholar 73 Langemeijer JJM, DeWildt DJ, DeGroot G, et al: Cardiorespiratory depression and hemolysis due to thioridazine overdose in the rat. J Pharm Pharmacol 1985; 37: 481–485. 10.1111/j.2042-7158.1985.tb03044.x CASPubMedWeb of Science®Google Scholar 74 Kuruvilla A, Stephen PM: Study on the antiarrhythmic effects of some centrally acting drugs-benzodiazepines. Indian J Exp Biol 1983; 21: 23–26. CASPubMedWeb of Science®Google Scholar 75 Lathers CM, Lipka LJ: Chlorpromazine: Cardiac arrhythmogenicity in the cat. Life Sci 1986; 38: 521–538. 10.1016/0024-3205(86)90031-7 CASPubMedWeb of Science®Google Scholar 76 Wilkerson RD: Antiarrhythmic effects of tricyclic antidepressant drugs in ouabain-induced arrhythmias in the dog. J Pharmacol Exp Ther 1978; 206: 666–674. Google Scholar 77 Basu Basu BN, Dutta SN, Booker WM: Effects of lithium chloride, desmethylimipramine and cocaine on the cardiovascular actions of ouabain in dogs with or without carotid and aortic baroreceptor reflexes. Arch Int Pharmacodyn Ther 1977; 228: 99–107. PubMedGoogle Scholar 78 Attree T, Sawyer P, Turnbull MJ: Interaction between digoxin and tricyclic antidepressants in the rat. Eur J Pharmacol 1972; 19: 294–296. 10.1016/0014-2999(72)90025-8 CASPubMedWeb of Science®Google Scholar 79 Kuruvilla A, Stephen PM: Effect of chlordiazepoxide on experimentally induced centrogenic arrhythmias in anesthetized dogs. Indian J Exp Biol 1984; 22: 653–656. CASPubMedWeb of Science®Google Scholar 80 Gillis RA, Thibodeaux H, Barr L: Antiarrhythmic properties of chlordiazepoxide. Circulation 1974; 49: 272–282. 10.1161/01.CIR.49.2.272 CASPubMedWeb of Science®Google Scholar 81 Pearl DS, Quest JA, Gillis RA: Effect of diazepam on digitalis-induced ventricular arrhythmias in the cat. Toxicol Appl Pharmacol 1978; 44: 643–652. 10.1016/0041-008X(78)90270-3 CASPubMedWeb of Science®Google Scholar 82 Gascon AL: Effect of acute stress and ouabain administration on adrenal catecholamine content and cardiac function of rats pretreated with diazepam. Can J Physiol Pharmacol 1977; 55: 65–71. 10.1139/y77-009 CASPubMedWeb of Science®Google Scholar 83 Brissette Y, Gascon AL: Increase in cardiac toxicity of ouabain in dogs after repetitive treatment with diazepam. Toxicol Appl Pharmacol 1978; 44: 127–135. 10.1016/0041-008X(78)90291-0 CASPubMedWeb of Science®Google Scholar 84 Lathers CM, Roberts J: Are the sympathetic neural effects of digoxin and quinidine involved in their action on cardiac rhythm? J Cardiovasc Pharmacol 1985; 7: 350–360. 10.1097/00005344-198503000-00022 CASPubMedWeb of Science®Google Scholar 85 Pace DG, Quest JA, Gillis RA: The effect of the vagus nerves on the bradycardia and ventricular arrhythmias induced by digitoxin and digoxin. Eur J Pharmcol 1974; 28: 288–293. 10.1016/0014-2999(74)90281-7 CASPubMedWeb of Science®Google Scholar 86 Caldwell RW, Puryear SK, Nash CB: Interaction of sympathetic nervous system in cardiac toxicity of digoxin or aminosugar cardiac glycosides. Proceedings of the Seventh International Congress for Pharmacology, Paris 1978; 914. Google Scholar 87 Cook LS, Caldwell RW, Nash CB, et al: Adrenergic and cholinergic mechanisms in digitalis inotropy. J Pharmacol Exp Ther 1982; 223: 761–765. CASPubMedWeb of Science®Google Scholar 88 Crankshaw DP, Raper C: The effect of solvents on the potency of chlordiazepoxide, diazepam, medazepam, and nitrazepam. J Pharm Pharmacol 1971; 23: 313–321. 10.1111/j.2042-7158.1971.tb09920.x CASPubMedWeb of Science®Google Scholar 89 Pearl DS, Quest JA, Gillis RA: Effect of diazepams on digitalis-induced ventricular arrhythmics in the cat. Toxicol Appl Pharmacol 1978; 44: 653–656. 10.1016/0041-008X(78)90271-5 CASPubMedWeb of Science®Google Scholar 90 Ceremuzynski L, Staszewska-Barczak J, Herbaczynska-Cedro K: Cardiac rhythm disturbances and the release of catecholamines after acute coronary occlusion in dogs. Cardiovasc Res 1969; 3: 190–197. 10.1093/cvr/3.2.190 PubMedWeb of Science®Google Scholar 91 Kelliher GJ, Widmer C, Roberts J: Influence of the adrenal medulla on cardiac rhythm disturbances following acute coronary artery occlusion, in P Roy, G Rona (eds): Recent Advances in Studies on Cardiac Structure and Metabolism, vol 10: The Metabolism of Contraction. Baltimore, University Park Press, 1975; 387–400. Google Scholar 92 Banks P: The effect of ouabain on the secretion of catecholamines and on the intracellular concentration of potassium. J Physiol (Lond) 1967; 193: 631–637. 10.1113/jphysiol.1967.sp008383 CASPubMedWeb of Science®Google Scholar 93 Nadeau R, DeChamplain J: Comparative effects of 6-hydroxydopamine and reserpine on ouabain toxicity in the rat. Life Sci 1973; 13: 1753–1761. 10.1016/0024-3205(73)90122-7 CASPubMedWeb of Science®Google Scholar 94 Gascon AL, Lelorier J: Increase in catecholamine content of the rat adrenals after pretreatment with diazepam. Can J Physiol Pharmacol 1975; 53: 1198–1199. 10.1139/y75-167 CASPubMedWeb of Science®Google Scholar 95 Carlsson C, Dencker SJ, Grimby G, et al: Noradrenaline in blood-plasma and urine during chlorpromazine treatment. Lancet 1966; 1: 1208. 10.1016/S0140-6736(66)91096-8 Web of Science®Google Scholar 96 Weil-Malherbe H: The biphasic effect of phenothiazines on the release of adrenaline from adrenomedullary granules and its dependence on pH, in GB Koelle, WW Douglas, A Carlssan, Z Trcka (eds): Pharmacology of Cholinergic and Adrenergic Transmission. New York, Macmillian, 1965; 235–239. 10.1016/B978-0-08-010805-6.50026-8 Google Scholar 97 Lathers CM, Flax RF, Lipka LJ: The effect of C1 spinal cord Transection or bilateral adrenal vein ligation on thioridazine-Induced arrhythmia and death in the cat. J Clin Pharmacol 1986; 26: 515–523. 10.1002/j.1552-4604.1986.tb02944.x CASPubMedWeb of Science®Google Scholar 98 Abildskov JA: The nervous system and cardiac arrhythmias. Circulation 1975; 52(suppl 3): 116–119. Google Scholar 99 Evans DE, Gillis RA: Effect of diphenylhydantoin and lidocaine on cardiac arrhythmias induced by hypothalamic stimulation. J Pharmacol Exp Ther 1974; 191: 506–517. CASPubMedWeb of Science®Google Scholar 100 Evans DE, Gillis RA: Effect of ouabain and its interaction with diphenylhydantoin on cardiac arrhythmias induced by hypothalamic stimulation. J Pharmacol Exp Ther 1975; 195: 577–586. CASPubMedWeb of Science®Google Scholar 101 Evans DE, Gillis RA: Reflex mechanisms involved in cardiac arrhythmias induced by hypothalamic stimulation. Am J Physiol 1978; 234: H199–H209. PubMedWeb of Science®Google Scholar 102 Grossman MA: Cardiac arrhythmias in acute central nervous system disease. Successful management with stellate ganglion block. Arch Intern Med 1976; 136: 203–207. CASPubMedWeb of Science®Google Scholar 103 Abildskov JA, Millar K, Burgess MJ, et al: The electrocardiogram and the central nervous system. Prog Cardiovasc Dis 1980; 13: 210–216. 10.1016/0033-0620(70)90009-5 PubMedGoogle Scholar 104 Talman WT: Cardiovascular regulation and lesions of the central nervous system. Ann Neurol 1985; 18: 1–12. 10.1002/ana.410180102 CASPubMedWeb of Science®Google Scholar 105 Weaver LC, Akera T, Brody TM: Opposing responses in sympathetic nerve activity induced by central injections of ouabain. J Pharmacol Exp Ther 1975; 195: 114–125. CASPubMedWeb of Science®Google Scholar 106 Weaver LC, Akera T, Brody TM: Digoxin toxicity: Primary sites of drug action on the sympathetic nervous system. J Pharmacol Exp Ther 1976; 197: 1–9. CASPubMedWeb of Science®Google Scholar 107 Pace DG, Gillis RA: Neuroexcitatory effects of digoxin in the cat. J Pharmacol Exp Ther 1976; 199: 583–600. CASPubMedWeb of Science®Google Scholar 108 Kao A, Kriett JM, Tobler HG, et al: Bromocriptine treatment of digitalis-induced ventricular tachyarrhythmias: Studies in a canine model. J Am Cell Cardiol 1984; 4: 1188–1194. 10.1016/S0735-1097(84)80137-0 CASPubMedWeb of Science®Google Scholar 109 Sayed Y, Garrison JM: The dopamine hypothesis of schizophrenia and the antagonistic action of neuroleptic drugs-a review. Psychopharmacol Bull 1983; 19: 283–288. CASPubMedWeb of Science®Google Scholar 110 Beleslin DB, Jovanovic-Micic D, Japundzu N, et al: Behavioral, autonomic and motor effects of neuroleptic drugs in cats: Motor impairment and aggression. Brain Res Bull 1985; 15: 353–356. 10.1016/0361-9230(85)90164-9 CASPubMedWeb of Science®Google Scholar 111 Snyder SH, Banerjee SP, Yamamura HI, et al: Drugs, neurotransmitters, and schizophrenia. Science 1974; 184: 1243–1253. 10.1126/science.184.4143.1243 CASPubMedWeb of Science®Google Scholar 112 Tangri KK, Bhargava KP: The central hypotensive action of 1-hydrazinophthalazine (C-5968). Arch Int Pharmacodyn Ther 1960; 125: 331–342. CASPubMedWeb of Science®Google Scholar 113 Weinberg SJ, Haley TJ: Effect of chlorpromazine on cardiac arrhythmias induced by intracerebral injection of tryptamine-strophanthidin. Arch Int Pharmacodyn Ther 1956; 105: 209–220. CASPubMedWeb of Science®Google Scholar 114 Wang HH, Kanai T, Markee S, et al: Effects of reserpine and chlorpromazine on the vasomotor center in the medulla oblongata of the dog. J Pharmacol Exp Ther 1964; 144: 186–195. CASPubMedWeb of Science®Google Scholar 115 Lipka LJ, Lathers CM: Cardiovascular effects of intracerebroventricular administration of chlorpromazine in the cat (abstract). J Clin Pharmacol 1985; 25; 462. Web of Science®Google Scholar 116 Gosa D, Marcu D, Caliman I, et al: The effects of some neurotropic and psychotropic agents on centrogenic sodium glutamate induced cardiac arrhythmias in anesthetized rats. Agressologie 1983; 24: 19–22. CASPubMedGoogle Scholar 117 Nattel S, Keable H, Sasyniuk BI: Experimental amitriptyline intoxication: Electrophysiologic manifestations and management. J Cardiovasc Pharmacol 1984; 6: 83–89. 10.1097/00005344-198401000-00013 CASPubMedWeb of Science®Google Scholar 118 Madan BR, Pendse VK: Antiarrhythmic activity of thioridazine hydrochloride (Mellaril). Am J Cardiol 1963; 11: 78–81. 10.1016/0002-9149(63)90035-3 CASWeb of Science®Google Scholar 119 Uhl JA: Phenytoin: The drug of choice in tricyclic antidepressant overdose? Ann Emerg Med 1981; 10: 270–274. 10.1016/S0196-0644(81)80056-X CASPubMedWeb of Science®Google Scholar 120 Matsuo S: Comparative effects of imipramine and propranolol on the transmembrane potentials of the isolated rabbit's atria. Jpn J Pharmacol 1967; 17: 279–286. 10.1254/jjp.17.279 CASPubMedWeb of Science®Google Scholar 121 Marmo E, Cosciia L, Cataldi S: Cardiac effects of antidepressants. Jpn J Pharmacol 1972; 22: 283–292. 10.1254/jjp.22.283 CASPubMedWeb of Science®Google Scholar 122 Wilkerson RD, Sanders PW: The antiarrhythmic action of amitriptyline on arrhythmias associated with myocardial infarction in dogs. Eur J Pharmacol 1978; 51: 193–198. 10.1016/0014-2999(78)90404-1 CASPubMedWeb of Science®Google Scho
Referência(s)